Loading...
Cross Country Healthcare announced strong second quarter 2022 results with revenue increasing 127% year-over-year to $753.6 million and net income attributable to common stockholders increasing 358% year-over-year to $52.9 million.
Revenue and Adjusted EBITDA exceeded guidance ranges
Record number of professionals on assignment
Double-digit year-over-year growth across all lines of business
Adjusted EBITDA margin of 11.1%
The guidance below applies to management’s expectations for the third quarter of 2022.
Visualization of income flow from segment revenue to net income